In this research, the procedure under study is represented:
In this research, the procedure under study is represented:: * On the one hand, by carrying out sexology consultations which consist of individual interviews with a qualified sexologist nurse.
* Secondly, questionnaires to assess quality of life and sexual function, to be completed by patients during standard follow-up consultations; and a questionnaire on satisfaction with sexological follow-up, to be completed by patients and their partners (if applicable) during the last standard follow-up consultation.
Study summary
Single-centre prospective pilot study designed to demonstrate the acceptability of onco-sexology management for laryngectomy patients and their partners in order to improve their perception of their intimate life. This is a non-interventional study (category 3 Loi Jardé), which will not result in any change in patient management. All procedures will be carried out in accordance with standard practice.
Patients will be followed for 14 months.
Eligibility
Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria:
For patients:
1. Patient to be treated for ORL cancer by total (pharyngo)laryngectomy
2. Patient WHO 0-1-2
3. Age greater than or equal to 18 years
4. Patient who has not objected to participation in the study.
For partners (if applicable) :
1. Age greater than or equal to 18 years
2. Subject who has not objected to participation in the study.
Exclusion Criteria:
For patients:
1. Patient with another co-existing malignant disease at the time of inclusion.
2. Any psychological, familial, geographical or sociological condition that does not allow for compliance with the medical follow-up and/or procedures foreseen in the study protocol.
3. Patients deprived of their liberty or under legal protection (guardianship and tutorship, safeguard of justice).
For partners (if applicable):
1\. Patients deprived of their liberty or under legal protection (guardianship and tutorship, safeguard of justice).
Primary outcome measure(s)
The primary endpoint is defined as the rate of patients meeting the acceptability criteria for onco-sexology management. — 14 months for each patient This rate corresponds to the ratio of the number of patients meeting the acceptability criteria to the total number of patients included.
Acceptability is defined when the following two criteria are validated:
* Completion of onco-sexology consultations 2 and 3 (at 3 and 12 months after cancer treatment)
* Patient satisfaction ≥ 3 on a numerical scale from 1 to 5.
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.
